Page last updated: 2024-10-29

indirubin-3'-monoxime and Neurogenic Inflammation

indirubin-3'-monoxime has been researched along with Neurogenic Inflammation in 1 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Neurogenic Inflammation: Inflammation caused by an injurious stimulus of peripheral neurons and resulting in release of neuropeptides which affect vascular permeability and help initiate proinflammatory and immune reactions at the site of injury.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sathiya Priya, C1
Vidhya, R1
Kalpana, K1
Anuradha, CV1

Other Studies

1 other study available for indirubin-3'-monoxime and Neurogenic Inflammation

ArticleYear
Indirubin-3'-monoxime prevents aberrant activation of GSK-3β/NF-κB and alleviates high fat-high fructose induced Aβ-aggregation, gliosis and apoptosis in mice brain.
    International immunopharmacology, 2019, Volume: 70

    Topics: Amyloid beta-Peptides; Animals; Apoptosis; Brain; Diet, High-Fat; Disease Models, Animal; Fructose;

2019